Crestor Tablet, Film Coated
Product Images NDC 0310-7570

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 0310-7570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg 90 Tablet Bottle Label

10 mg 90 Tablet Bottle Label
This is a description of the prescription medication CRESTOR, containing rosuvastatin calcium. It is produced and trademarked by the AstraZeneca group of companies and intended for use only with a prescription. The package contains 90 tablets and is manufactured in Belgium. The pharmaceutical company responsible for distribution in the US is AsiraZeneca Pharmaceuticals LP, based in Wilmington, Delaware, while IP Pharmaceuticals, Inc. of Canivanas, Puerto Rico is the manufacturer. The provided text includes a product number, a barcode, and copyright information for AstraZeneca from 2021.*
FDA Label Image

40_mg_bottle_label (40 mg Bottle Label)

40_mg_bottle_label (40 mg Bottle Label)
Description: CRESTOR is a prescription drug produced by AstraZeneca, which contains rosuvastatin calcium. This medicine is used to lower cholesterol and triglycerides in the blood. It is available in tablets of 30 each and is dispensed by AstraZeneca Pharmaceuticals LP. The drug is made in Belgium and is distributed by IPR Pharmaceuticals Inc, located in Canévanas, PR, USA. This information is provided on the product label, which also states that CRESTOR is a trademark of the AstraZeneca group of companies (© AstaZeneca 2021).*
FDA Label Image

5 mg 90 Tablet Bottle Label

5 mg 90 Tablet Bottle Label
This text is a label of CRESTOR, a trademarked medication from AstraZeneca group, consisting of rosuvastatin calcium. It comes in the form of 5mg tablets that should be taken strictly under prescription. The label displays product information like the National Drug Code (NDC), manufacturer's name and location, and product quantity, which is 90 tablets. The medication is produced in Belgium, and the label has a copyright date of 2021 for AstraZeneca.*
FDA Label Image

Figure_1 (Figure 1)

FDA Label Image

Figure_2 (Figure 2)

FDA Label Image

Figure_3 (Figure 3)

Figure_3 (Figure 3)
The text describes the number of events and endpoint results for Rosuva 20mg and Placebo 20mg, including primary end points, cardiovascular death, nonfatal stroke, nonfatal MI, and arterial revascularization. Hazard ratios and P values are also shown.*
FDA Label Image

Image 01

Image 01
This is a description for a medication called CRESTOR which contains rosuvastatin calcium. The trademark belongs to the AstraZeneca group and it comes in the form of 90 tablets that are available only by prescription. The text also mentions the location of the manufacturer and the product origin which is Belgium.*
FDA Label Image

Structural_formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.